Ligilactobacillus salivarius PS11610 Enhances the Fertilization Success of IVF: A Preliminary Retrospective Analysis
Nutrients · 23.01.2025 · 17 (3) · 410
DOI: 10.3390/nu17030410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 23.01.2025. Verfasst von Miguel Raimundo und 4 weiteren Autor:innen. Beteiligte Einrichtung: NOVA National School of Public Health, NOVA University Lisbon, 1600-560 Lisbon, Portugal. Hauptthemen laut MEDLINE: Fertilization in Vitro, Probiotics, Lactobacillus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Infertility affects couples at reproductive age, with in vitro fertilization (IVF) being the most effective treatment. Success rates of IVF are influenced by several factors, including a healthy female reproductive system microbiome, which can improve implantation rates and pregnancy outcomes. This study evaluated the impact of Ligilactobacillus salivarius PS11610 on IVF outcomes. This strain showed antimicrobial activity against pathogens related to dysbiosis, commonly observed in women undergoing assisted reproductive treatment.
Results
The administration of L. salivarius PS11610 at a dose of 1 × 109 CFU every 12 h for at least one month before IVF procedures, particularly in the frozen embryo transfer (FET) group, appears to enhance the success rate of IVF. IVF procedures without embryo transfer showed no significant differences between the groups. However, there were statistically significant differences in the quality of embryos, specifically in category 2, which were higher in the group without L. salivarius PS11610 supplementation (p = 0.042). Similar results were seen in the IVF with embryo transfer group, where the quality of embryos in categories 2 and 3 was higher in the group without L. salivarius PS11610 (p = 0.019 and p = 0.05, respectively). IVF with FET showed notable improvements, where intake of L. salivarius PS11610 was associated with a significant increase in live birth infants (26.4% with L. salivarius PS11610 vs. 17.9% without, p = 0.034) and higher biochemical pregnancy rates (42.6% vs. 34%, p = 0.071).
Conclusions
Despite some differences in embryo quality, the overall positive impact on pregnancy and birth outcomes highlights L. salivarius PS11610 as a promising supplement in assisted reproductive treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NOVA National School of Public Health, NOVA University Lisbon, 1600-560 Lisbon, Portugal.
- School of Psychology and Life Sciences, Lusófona University Lisbon, 1749-024 Lisbon, Portugal.
- Probisearch SLU, 28760 Tres Cantos, Spain.
ORCID-Profile: Miguel Raimundo, Patrícia Rodrigues, Irene Espinosa-Martos, Esther Jiménez
Zitieren
APA
Raimundo, M., Rodrigues, P., Esteban, S., Espinosa-Martos, I., & Jiménez, E. (2025). Ligilactobacillus salivarius PS11610 Enhances the Fertilization Success of IVF: A Preliminary Retrospective Analysis. Nutrients, 17(3), 410. https://doi.org/10.3390/nu17030410
Vancouver
Raimundo M, Rodrigues P, Esteban S, Espinosa-Martos I, Jiménez E. Ligilactobacillus salivarius PS11610 Enhances the Fertilization Success of IVF: A Preliminary Retrospective Analysis. Nutrients. 2025;17(3):410. doi:10.3390/nu17030410
BibTeX
@article{Raimundo2025,
author = {Raimundo, Miguel and Rodrigues, Patrícia and Esteban, Sergio and Espinosa-Martos, Irene and Jiménez, Esther},
title = {Ligilactobacillus salivarius PS11610 Enhances the Fertilization Success of IVF: A Preliminary Retrospective Analysis},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {3},
pages = {410},
doi = {10.3390/nu17030410}
}
EUVIMED